Host inflammatory dynamics reveal placental immune modulation by Group B Streptococcus during pregnancy.
Felicia KuperwaserGal AvitalMichelle J VazKristen N NobleAllison N DammannTara M RandisDavid M AronoffAdam J RatnerItai YanaiPublished in: Molecular systems biology (2023)
Group B Streptococcus (GBS) is a pathobiont that can ascend to the placenta and cause adverse pregnancy outcomes, in part through production of the toxin β-hemolysin/cytolysin (β-h/c). Innate immune cells have been implicated in the response to GBS infection, but the impact of β-h/c on their response is poorly defined. We show that GBS modulates innate immune cell states by subversion of host inflammation through β-h/c, allowing worse outcomes. We used an ascending mouse model of GBS infection to measure placental cell state changes over time following infection with a β-h/c-deficient and isogenic wild type GBS strain. Transcriptomic analysis suggests that β-h/c-producing GBS elicit a worse phenotype through suppression of host inflammatory signaling in placental macrophages and neutrophils, and comparison of human placental macrophages infected with the same strains recapitulates these results. Our findings have implications for identification of new targets in GBS disease to support host defense against pathogenic challenge.
Keyphrases
- immune response
- wild type
- mouse model
- oxidative stress
- pregnancy outcomes
- escherichia coli
- single cell
- endothelial cells
- pregnant women
- biofilm formation
- metabolic syndrome
- stem cells
- type diabetes
- emergency department
- skeletal muscle
- cystic fibrosis
- pulmonary artery
- insulin resistance
- staphylococcus aureus
- genome wide
- pulmonary hypertension
- weight loss
- bone marrow
- mesenchymal stem cells